Journal of Research and Development
Open Access
ISSN: 2311-3278
ISSN: 2311-3278
USA
Extended Abstract
Nanomedicine 2017: Anti-fusion targeted nanomicellar theranostics: Novel antiviral strategies for respiratory syncytial virus infection-induced lung disease
Author(s): Shyam S Mohapatra
The respiratory syncytial virus (RSV), is an important pathogen that infects an estimated 64 million people and causes ~200,000 deaths globally every year. Despite progress in the biology of RSV, there is no effective treatment or vaccine against RSV infection. Currently, only high-risk infants receive antibody-based prophylaxis, which is expensive and moderately effective in reducing hospitalization. Therefore, a broadly applicable, effective and inexpensive approach to prevent or treat RSV-bronchiolitis or pneumonia remains an urgent unmet need. We have been investigating nanomedical approaches against RSV infection and have reported on .. View More»